Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{| | {| | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! | ! colspan="2" rowspan="4" |Disease | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ||
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | ! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | ||
Line 14: | Line 13: | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ||
|- | |- | ||
! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
Line 31: | Line 28: | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired | ||
Line 51: | Line 47: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ||
! | ! colspan="2" |Hodgkin's Lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 84: | Line 79: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ||
! | ! colspan="2" |Precursor B-cell lymphoblastic leukemia/lymphoma | ||
| | | | ||
* Precursor B-cell Lymphoma | * Precursor B-cell Lymphoma | ||
Line 117: | Line 111: | ||
|- | |- | ||
! | ! | ||
| | | colspan="2" |[[Follicular lymphoma]] | ||
|[[Follicular lymphoma]] | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 162: | Line 155: | ||
|- | |- | ||
! | ! | ||
| | | colspan="2" |Mantle cell lymphoma | ||
|Mantle cell lymphoma | |||
| | | | ||
* [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | * [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | ||
Line 221: | Line 213: | ||
|- | |- | ||
! | ! | ||
| | | colspan="2" |Diffuse large B cell lymphoma | ||
|Diffuse large B cell lymphoma | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 271: | Line 262: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! | ! colspan="2" |Disease | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ||
Line 302: | Line 292: | ||
|- | |- | ||
! | ! | ||
! | ! colspan="2" |[[Burkitt lymphoma]] | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 364: | Line 353: | ||
|- | |- | ||
! | ! | ||
| | | colspan="2" |B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | ||
|B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 396: | Line 384: | ||
|- | |- | ||
! | ! | ||
|Marginal zone lymphoma | | rowspan="3" |Marginal zone lymphoma | ||
|Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type | |Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type | ||
| | | | ||
Line 427: | Line 415: | ||
| | | | ||
|- | |- | ||
| | | | ||
|[[Splenic marginal zone lymphoma]] | |[[Splenic marginal zone lymphoma]] | ||
Line 474: | Line 461: | ||
| | | | ||
|- | |- | ||
| | | | ||
|[[Nodal marginal zone B-cell lymphoma]] | |[[Nodal marginal zone B-cell lymphoma]] | ||
Line 524: | Line 510: | ||
|- | |- | ||
| | | | ||
| | | colspan="2" |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | ||
|Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 556: | Line 541: | ||
|- | |- | ||
| | | | ||
| | | colspan="2" |[[Hairy cell leukemia]] | ||
|[[Hairy cell leukemia]] | |||
| | | | ||
* Production of [[Cytokine|cytokines]], such as [[TNF alpha]] and IL-2R, provide important stimuli for [[malignant]] [[B cell|B cells]] proliferation in hairy cell leukemia. | * Production of [[Cytokine|cytokines]], such as [[TNF alpha]] and IL-2R, provide important stimuli for [[malignant]] [[B cell|B cells]] proliferation in hairy cell leukemia. | ||
Line 619: | Line 603: | ||
|- | |- | ||
| | | | ||
| | | colspan="2" |Precursor T-cell lymphoblastic leukemia/lymphoma | ||
|Precursor T-cell lymphoblastic leukemia/lymphoma | |||
| | | | ||
* '''Precursor T-cell Lymphomas''' | * '''Precursor T-cell Lymphomas''' | ||
| | | | ||
Line 653: | Line 635: | ||
|- | |- | ||
| | | | ||
| | | colspan="2" |Adult T cell leukemia/lymphoma | ||
|Adult T cell leukemia/lymphoma | |||
| | | | ||
| | | | ||
Line 684: | Line 665: | ||
|- | |- | ||
|T cell lymphoma | |T cell lymphoma | ||
| | | colspan="2" |Anaplastic large cell lymphoma | ||
|Anaplastic large cell lymphoma | |||
| | | | ||
| | | |
Revision as of 18:49, 31 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
|
CBC
|
|
|
|||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic:
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|
||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |